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INTRODUCTION:  The  gangliocytic  paraganglioma  (GP)  is  an  extremely  rare  neuroendocrine  tumour  orig-
inating from  the  second  part  of the  duodenum.  Generally  GP  shows  benign  clinical  behaviour.  The  GP  is
typically  characterized  by consisting  of three  tumour  components:  the  epithelioid,  the  spindle-shaped
and  the  ganglion-like  cells.
PRESENTATION  OF  CASE:  We  present  a female  patient  at the  age of 65, who  underwent  a  routine  gas-
troscopy  due  to known  gastro-oesophageal  reﬂux.  Accidentally  a 2 ×  1,5 cm  sized  mass  of  unknown  entity
was  revealed  in the duodenum.  The  magnet  resonance  tomography  neither  detected  distant  metastasis
nor  any  local  lymphadenopathy.  After  endosonographically  guided  punctures  of  the  submucosal  mass,
a malignant  tumour  could  not  be diagnosed  thus  the  decision  to perform  an  endoscopical  resection  was
made and  successfully  conducted.  Immunohistochemical  examination  revealed  a  total  resected  GP.
DISCUSSION:  In literature  malignant  transformation  with  distant  metastasis  and  local  recurrences  has
been  described.  Furthermore  the  clinical  manifestation  and  location  varies.  The  GP has  often  been  mis-
diagnosed  as  a neuroendocrine  tumour  (NET)  G1.
CONCLUSION:  Due  to published  cases  of  metastasising  GPs,  we  recommend  a  long  term  follow-up.  In
a  non-metastatic  stage  the  endoscopic  resection  should  be the therapy  of  choice  in order  to  prevent
unnecessary  major  surgical  interventions.  In  this  case  report  we  will  discuss  the  clinical  appearance,
behaviour  and  differential  diagnosis  of  GP.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
The GP is a rare submucosal gastrointestinal tumour with mostly
enign clinical behaviour. The tumour was ﬁrst described by Dahl
t al. in 1957 [1]. Generally the GP is characterized by consisting of
hree tumour components: spindle-shaped cells with Schwannian
ifferentiation, ganglion-like cells and neuroendocrine cells [2,3].
hese cells can be immunoreactive to pancreatin, synaptophysin,
hromogranin and are able to express S-100, NSE, pancreatic
olypeptide, somatostatin and vasoactive intestinal peptide [2].
he spindle cells are characterized by forming fascicles or envelope
erve cells and axons expressing the S100 protein. The ganglion
ells are scattered as single elements or appear aggregated in clus-
ers [4].The GP typical occurs in the 5th decade of life [5]. Men  are more
ften affected than women (1,8: 1). A literature review by Okubo
t al. revealed that approximately 90% of the published cases of
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210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
GPı´s originate from the duodenum [2]. These tumours are classiﬁed
as neoplasia of the digestive tract by the World Health Organisa-
tion [4]. In literature the GP has been described as appearing in the
esophagus, jejunum, pylorus and even in the retroperitoneal space
[6]. The main symptoms are mostly abdominal pain, discomfort,
anaemia and upper gastrointestinal bleeding. To diagnose a GP can
be extremely challenging. Due to the submucosal location of GP, an
endoscopic biopsy often times presents negative results [4]. More-
over a GP can be conﬁrmed by computer tomography, ultrasound
imaging, magnet resonance tomography and detection of neuronal
and neuroendocrine markers such as synaptophysin, chromogranin
A, CD56, S-100, NSE and somatostatin in the blood [7]. Additionally
the diagnosis can be supported by immunohistochemical ﬁndings
such as oestrogen, progesterone receptors, pancreatic polypeptide,
somatostatin and vasoactive intestinal polypeptide (VIP) [7]. Ther-
apy of choice is the local endoscopic excision. In case of lymph
node or distant metastasis, a pancreaticoduodenectomy is recom-
mended [8].Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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F m sized mass in the duodenum (marked by white dashed arrow). Distant metastasis and
l hy does not reveal a tumour originating from the bilious duct system (B).
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sig. 1. Magnetic resonance imaging of the upper abdomen (A). Visible is a 2 × 1,5 c
ymphadenopathy are not visible. The magnetic resonance cholangiopancreatograp
. Presentation of case
In November 2015 a 65 year old women was treated in
ur hospital due to a submucosal tumour of uncertain origin.
er medical history included a diverticulosis and rheuma-
oid arthritis. The patient suffered from a hiatus hernia and
astro-oesophageal reﬂux. Therefore she routinely underwent a
astroscopy at her local hospital, where a 2 × 1,5 cm sized mass
as found in the second part of the duodenum. After performing
agnetic resonance tomography with cholangiopancreatogra-
hy distant metastasis and lymphadenopathy were not detected
Fig. 1).
Due to the submucosal location several attempts to obtain a
istopathological diagnose of the tumour were unsuccessful. Under
uspicion of a malignant tumour such as carcinoma of the duodenal
apilla the patient was advised to undergo an open surgery explo-
ation. She rejected the proposal, yet she came to our hospital for a
econd opinion and further diagnostic.
The physical examination did not reveal any pathological
ndings. Furthermore the laboratory test demonstrated normal
evels of C-reactive protein, leucocytes, CA72-4 and CA19-9. The
umour marker CEA was slightly increased (4,1 g/l). We  per-
ormed a gastroduodenoscopy with ultrasound guided puncture
nd endosonographic imaging of the submucosal tumour. The
ass was anechoic and seemed to be located in all wall layers.
wollen lymph nodes were not detected. The histopathological
xamination revealed a tumour arising from the submucosa, cov-
red by mucous membrane and surrounded by smooth muscle.
ue to the lack of distant metastasis and lymphadenopathy, the
ecision for an endoscopic removal of the tumour was  made.
nder analgesic sedation we performed a gastroduodenoscopy.
he mass of unclear entity was located approximately 2 cm above
he Papilla vateri.  After submucosal injection with adrenalin and
ucosal dissection the tumour was successfully removed via
autery snare. The mass seemed to originate from the muscu-
aris propria. The defect of the mucosa was covered with two
lips (Fig. 3). The post interventional course was  without com-
lications and the patient left the hospital within the next 2 days
Fig. 2).
.1. Pathological ﬁndingsThe histopathological examination reveal a GP. Fig. 4 shows a
9 × 15 × 10 mm large tumour with yellow-grey cut surface as a
ubmucosal mass with trilinear differentiation.Fig. 2. The Figure indicates the timeline of this case report.
2.2. Immunohistochemical ﬁndings
Immunohistochemical ﬁndings are imaged in Fig. 5. Neuronal,
gangliocytic and nest-like epitheloid structures are imaged in Pic-
ture 1. The S100 expression of spindle cell with Schwann-like
differentiation is imaged in Picture 2. The neuroendocrine cell and
ganglion cells show synaptophysin expression is demonstrated in
Picture 3. The VIP expression is shown in Picture 4.As follow-up diagnostic we  performed a gastroduodenoscopy 3
month after the endoscopic removal of the GP. No recurrence was
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Fig. 3. Images of the gastroduodenoscopy. The tumour was  located approximately 2 cm ab
dissection (C) the tumour was successfully removed via cautery snare. The defect of the m
Fig. 4. The GP is shown with yellow-grey cut surface as a submucosal mass with
trilinear differentiation. (HE staining, Magniﬁcation 4×).ove the Papilla vateri (A). After submucosal injection with adrenalin (B) and mucosal
ucosa was covered with two clips (D).
revealed. Furthermore we recommended performing a gastroduo-
denoscopy as follow-up diagnostic annually.
3. Discussion
The periampullary GP is an extremely rare tumour entity. Its
exact origin still remains unclear. The GP is typically character-
ized by consisting of three tumour components: the epithelioid, the
spindle-shaped and the ganglion-like cells [7,3]. The GP is described
as being a tumour with benign clinical behaviour. In a literature
review Okubo et al. retrieved 192 patients with GP, 90% of them
being located in the duodenum [2]. In a follow up period from 12
to 96 months no death from GP was observed. Furthermore nei-
ther Raﬁullah nor Yang observed any relapses of duodenal GPs  in
their case reports during a long term follow up of 3 years [9,10].
Moreover Okubo et al. performed a multi-institutional retrospec-
tive study in japan [7]. No local recurrence or distant metastasis
were detected in 12 cases of mainly endoscopically removed duo-
denal GP. In contrast Li et al. published a case report of a 47-year-old
male patient suffering from a GP, which was removed via pancre-
aticoduodenectomy [3]. Four months after the removal computer
tomography imaging revealed distant metastasis in the liver and
pelvic cavity. The tumour did not show remarkable sensitivity to
chemo- or radiotherapy. The patient died after tumour progess with
fever and ascites. Also Armin et al. published a case of a GP that
developed liver metastasis spreading to the retropancreatic space
[6].The main symptoms of a GP are gastrointestinal bleeding and
abdominal pain. This tumour entity typically arises from the sec-
ond part of the duodenum [7]. In literature the description of its
clinical manifestation and location varies. Eeden et al. published a
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CP, MH,  FT took care of the patient. CP and FT wrote the
report. MH  preformed the endoscopic approach. FT revealed the
histopathological diagnose. All authors have read and approved the
ﬁnal manuscript.ig. 5. (Magniﬁcation 40×); Picture 1 demonstrates neuronal, gangliocytic and ne
xpressions are shown in these ﬁgure.
ase of 47 year old male patient revealing a GP in the appendix. This
umour was mimicking an acute appendicitis. Therefore he under-
ent an appendectomy [11]. Furthermore Lin et al. reported a case
f an asymptomatic 4 × 3,8 × 2,5 cm sized GP located in the right
ower lobe of the lung [12]. And Yang et al. diagnosed as well as
emoved a 1,6 cm sized tumour in the anterior mediastinum. Later
mmunohistochemical examination revealed a GP surrounded by
ormal thymic tissue [13]. The GP was even detected in the supe-
ior mediastinum and the esopahgus [14]. Vural et al. treated a
7-year-old boy due to low back pain and bilateral sciatica [15].
n intradural-extramedullary mass at the level of the L4, exiting
hrough intervertebral foramen into the right psoas muscle, was
iagnosed. The tumour was removed and a GP was found. Moreover
ahdavi et al. published a case report of a 55-year-old Caucasian
omen suffering from a cystic teratoma with nodules consisting
f GP [16]. Furthermore Sinkre et al. treated a 44-year-old woman
ith a GP in the nasopharynx. The tumour caused headaches and
ymptoms of abdominal fullness [17].
The GP is a rare neuroendocrine tumour, which has often been
isdiagnosed as a neuroendocrine tumour (NET) G1. Both tumour
ntities are, according to the WHO  classiﬁcation, “neuroendocrine
umours of the ampullary region” [4]. But a literature review by
kubo et al. showed that mitosis and prominent Ki-67 immunore-
ctivity, important markers for diagnosing of NET G1, were not
etected in any published cases of GP [7]. Also an immunohisto-
hemical examination comparing the GP and the NET G1 in the
eforehand mentioned review indicated a signiﬁcant higher posi-
ive reactivity for progesterone, estrogen receptors and pancreatic
olypeptide (PP) in the GP. Accordingly Armin et al. assumed that
P, which was detected in the serum of a patient suffering of metas-
asised GP, is a possible suitable marker for the differentiation of GP
rom NET [6]. In literature NET G1 in comparison to GP is described
s a being a tumour entity with a higher risk of metastasising, pri-
arily to lymph nodes and the liver [4]. It is therefore mandatory
o clearly differentiate the GP from NET G1 due to different thera-
eutic approaches.. Conclusion
The GP is a rare neuroendocrine tumour entity typical arising
rom the second part of the duodenum showing mostly benign clin- epitheloid structures in HE staining. The S100 (2), synaptophysin (3) and VIP (4)
ical behaviour. Due to several published cases of metastasising GPs,
we strongly recommend a long term follow-up.
In a non-metastatic stage the endoscopic resection should be the
therapy of choice in order to prevent unnecessary major surgical
interventions such as the pancreaticoduodenectomy.
Due to different therapeutic procedures, it is mandatory to
clearly differentiate the GP from the NET G1 via immunohistochem-
ical examination.
Conﬂicts of interest
All authors state that they have no conﬂicts of interest.
Funding
This research did not receive any speciﬁc grant from funding
agencies in the public, commercial, or not-for-proﬁt sectors.
Ethical approval
No ethical approval needed.
Consent
Written informed consent was  obtained from the patient for
publication of this case report and any accompanying images.
Authors’ contributionsGuarantor
Christoph Paasch.
 –  O
l of Su
R
[
[
[
[
[
[
[
[
O
T
p
cCASE  REPORT
C. Paasch et al. / International Journa
eferences
[1] E.V. Dahl, J.M. Waugh, D.C. Dahlin, Gastrointestinal ganglioneuromas; brief
review with report of a duodenal ganglioneuroma, Am.  J. Pathol. 33 (5) (1957)
953–965.
[2] Y. Okubo, M.  Wakayama, T. Nemoto, K. Kitahara, H. Nakayama, K. Shibuya, T.
Yokose, M.  Yamada, K. Shimodaira, D. Sasai, T. Ishiwatari, M. Tsuchiya, N.
Hiruta, Literature survey on epidemiology and pathology of gangliocytic
paraganglioma, BMC  Cancer 11 (2011) 187, http://dx.doi.org/10.1186/1471-
2407-11-187.
[3] B. Li, Y. Li, X.Y. Tian, B.N. Luo, Z. Li, Malignant gangliocytic paraganglioma of
the duodenum with distant metastases and a lethal course, World J.
Gastroenterol. 20 (41) (2014) 15454–15461, http://dx.doi.org/10.3748/wjg.
v20.i41.15454.
[4] P. Kleihues, D.N. Louis, B.W. Scheithauer, L.B. Rorke, G. Reifenberger, P.C.
Burger, W.K. Cavenee, The WHO  classiﬁcation of tumors of the nervous
system, J. Neuropathol. Exp. Neurol. 61 (3) (2002) 215–225, discussion
226-219.
[5] V. Narang, N. Behl, N. Sood, H. Puri, Gangliocytic paraganglioma of duodenum,
Case Rep. Pathol. 2013 (2013) 378582, http://dx.doi.org/10.1155/2013/
378582.
[6] S.M. Amin, N.W. Albrechtsen, J. Forster, I. Damjanov, Gangliocytic
paraganglioma of duodenum metastatic to lymph nodes and liver and
extending into the retropancreatic space, Pathologica 105 (3) (2013) 90–93.
[7] Y. Okubo, T. Nemoto, M.  Wakayama, N. Tochigi, M.  Shinozaki, T. Ishiwatari, K.
Aki, M. Tsuchiya, H. Aoyama, K. Katsura, T. Fujii, T. Nishigami, T. Yokose, Y.
Ohkura, K. Shibuya, Gangliocytic paraganglioma: a multi-institutional
retrospective study in Japan, BMC  Cancer 15 (2015) 269, http://dx.doi.org/10.
1186/s12885-015-1308-8.[8] J. Kwon, S.E. Lee, M.J. Kang, J.Y. Jang, S.W. Kim, A case of gangliocytic
paraganglioma in the ampulla of Vater, World J. Surg. Oncol. 8 (2010) 42,
http://dx.doi.org/10.1186/1477-7819-8-42.
[9] Raﬁullah, S. Tanimu, A.A. Onitilo, Gangliocytic paraganglioma, a rare
ampullary tumour treated with open transduodenal resection and
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
rgery Case Reports 29 (2016) 39–43 43
sphincteroplasty, BMJ  Case Rep. 2014 (2014), http://dx.doi.org/10.1136/bcr-
2013-202941.
10] J.I. Yang, J.S. Choi, G.H. Lee, B.W. Kim, S.J. Moon, M.S. Kang, H.J. Ahn, A case of
ampullary gangliocytic paraganglioma, Korean J. Intern. Med. 29 (3) (2014)
375–378, http://dx.doi.org/10.3904/kjim.2014.29.3.375.
11] S. van Eeden, G.J. Offerhaus, H.L. Peterse, K.P. Dingemans, H.L. Blaauwgeers,
Gangliocytic paraganglioma of the appendix, Histopathology 36 (1) (2000)
47–49.
12] D. Lin, Y. Hu, X. Xing, L. Ding, H. Liu, Y. Li, F. Xiang, Pulmonary gangliocytic
paraganglioma: a case report and review of the literature, Int. J. Clin. Exp.
Pathol. 7 (1) (2014) 432–437.
13] J.W. Yang, J. Han, H.W. Lee, S.Y. Cho, H.K. Kim, A rare case of thymic
gangliocytic paraganglioma, J. Pathol. Transl. Med. 50 (2) (2016) 165–167,
http://dx.doi.org/10.4132/jptm.2015.07.15.
14] D.M. Weinrach, K.L. Wang, M.G. Blum, A.V. Yeldandi, W.B. Laskin, Multifocal
presentation of gangliocytic paraganglioma in the mediastinum and
esophagus, Hum. Pathol. 35 (10) (2004) 1288–1291.
15] M.  Vural, A. Arslantas, S. Isiksoy, B. Adapinar, M. Atasoy, F. Soylemezoglu,
Gangliocytic paraganglioma of the cauda equina with signiﬁcant calciﬁcation:
ﬁrst description in pediatric age, Zentralbl. Neurochir. 69 (1) (2008) 47–50,
http://dx.doi.org/10.1055/s-2007-985162.
16] A. Mahdavi, B. Silberberg, V.K. Malviya, A.H. Braunstein, J. Shapiro,
Gangliocytic paraganglioma arising from mature cystic teratoma of the ovary,
Gynecol. Oncol. 90 (2) (2003) 482–485.
17] P. Sinkre, G. Lindberg, J. Albores-Saavedra, Nasopharyngeal gangliocytic
paraganglioma, Arch. Pathol. Lab. Med. 125 (8) (2001) 1098–1100, http://dx.
doi.org/10.1043/0003-9985(2001)125<1098:NGP>2.0.CO;2.uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
